An interventional study of Pentaspan, voluven, volulyte in Avascular Necrosis of Hip and Total Hip Replacement Arthroplasty, sponsored by Seoul National University Bundang Hospital. Completed at 1 site in South Korea. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2014-01-28.
Sponsored by Seoul National University Bundang Hospital · Not applicable and Interventional
The investigators administered different kinds of colloids before transfusion of red blood cell to patient undergoing total hip replacement arthroplasty. The investigators will compare the differences of changes in rotational thromboelastometry (ROTEM) data among them.
Seoul National University Bundang Hospital is the lead sponsor of 376 studies on the registry; 56 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Pentaspan is administered as a colloid.
Drug: Pentaspan, voluven, volulyte
Voluven is administered as a colloid.
Drug: Pentaspan, voluven, volulyte
Volulyte is administered as a colloid.
Drug: Pentaspan, voluven, volulyte
Drug pages: Hydroxyethyl Starch Derivatives · HES 130-0.4
Different colloids are administered during operation for replacement of blood loss before the transfusion of blood.
INTEM parameters change from preoperative values at post-operation
clotting time (sec), clot firmness time (sec), alpah angle, maximum clot firmness (mm)
Time frame: 30 minutes before operation and 30 minutes after operation
EXTEM parameters change from preoperative values at post-operation
clotting time (sec), clot firmness time (sec), alpah angle, maximum clot firmness (mm)
Time frame: 30 minutes before and 30 minutes after operation.
FIBTEM parameters change from preoperative values at post-operation
maximum clot firmness (mm)
Time frame: 30 min before and 30 min after operation
Infused total fluid volume
crystalloid and colloid
Time frame: Participants will be followed for the duration of THRA operation in operating room, an expected average tiem of 3 hours
Hemoglobin
Time frame: 30 minutes before operation and 30 minutes after operation
postoperative blood loss
Time frame: postoperative 1 day and 2 day
Hematocrit
Time frame: 30 minutes before operation and 30 minutes after operation
Platelet
Time frame: 30 minutes before operation and 30 minutes after operation
Prothrombin Time-Internatiolnal Normalized Ratio
Time frame: 30 minutes before operation and 30 minutes after operation
Activated Partial Thrombin Time
Time frame: 30 minutes before operation and 30 minutes after operation
electrolytes
Time frame: 30 minutes before operation and 30 minutes after operation
This study is completed, as verified in Jan 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Hydroxyethyl Starch Derivatives · HES 130-0.4
Seoul National University Bundang Hospital →